Literature DB >> 10633915

Development of irreversible lesions in the brain, heart and kidney following acute and chronic murine malaria infection.

P N Vuong1, F Richard, G Snounou, F Coquelin, L Rénia, F Gonnet, A G Chabaud, I Landau.   

Abstract

Irreversible pathological lesions were noted in the organs of mice infected with 1 of 3 rodent malaria species: Plasmodium chabaudi chabaudi, P. vinckei petteri and P. yoelii nigeriensis at different times during the course of the primary parasitaemia and long after microscopical clearance of the parasites. Moreover, similar lesions were also obtained when parasite levels were kept below 1% by subcurative drug treatment. The frequency and severity of the lesions correlated with the duration of the infection. Accumulation of tissue damage during chronic low-grade malaria infections has implications for the design of control measures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10633915     DOI: 10.1017/s0031182099005120

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  11 in total

1.  Reduction in testosterone concentration and its effect on the reproductive output of chronic malaria-infected male mice.

Authors:  Mathieu Barthelemy; Claude Gabrion; Gilles Petit
Journal:  Parasitol Res       Date:  2004-07-09       Impact factor: 2.289

2.  Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes.

Authors:  Françoise Benoit-Vical; Joël Lelièvre; Antoine Berry; Caroline Deymier; Odile Dechy-Cabaret; Jérôme Cazelles; Christophe Loup; Anne Robert; Jean-François Magnaval; Bernard Meunier
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

3.  Cerebral malaria in mice: interleukin-2 treatment induces accumulation of gammadelta T cells in the brain and alters resistant mice to susceptible-like phenotype.

Authors:  A Haque; H Echchannaoui; R Seguin; J Schwartzman; L H Kasper; S Haque
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

4.  Quinine distribution in mice with Plasmodium berghei malaria.

Authors:  Eric Pussard; Alexandra Bernier; Elyane Fouquet; Patrice Bouree
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jan-Mar       Impact factor: 2.441

5.  Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.

Authors:  Balwan Singh; Monica Cabrera-Mora; Jianlin Jiang; Mary Galinski; Alberto Moreno
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

Review 6.  Virulence in malaria: an evolutionary viewpoint.

Authors:  Margaret J Mackinnon; Andrew F Read
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

7.  Co-infection restrains Litomosoides sigmodontis filarial load and plasmodial P. yoelii but not P. chabaudi parasitaemia in mice.

Authors:  Gregory Karadjian; Dominique Berrebi; Nathalie Dogna; Nathaly Vallarino-Lhermitte; Odile Bain; Irène Landau; Coralie Martin
Journal:  Parasite       Date:  2014-04-10       Impact factor: 3.000

Review 8.  The effect of malaria and anti-malarial drugs on skeletal and cardiac muscles.

Authors:  Mauro Toledo Marrelli; Marco Brotto
Journal:  Malar J       Date:  2016-11-02       Impact factor: 2.979

9.  Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.

Authors:  Yuri C Martins; Leah Clemmer; Pamela Orjuela-Sánchez; Graziela M Zanini; Peng Kai Ong; John A Frangos; Leonardo J M Carvalho
Journal:  Malar J       Date:  2013-04-24       Impact factor: 2.979

10.  Self-reactivities to the non-erythroid alpha spectrin correlate with cerebral malaria in Gabonese children.

Authors:  Vincent Guiyedi; Youri Chanseaud; Constantin Fesel; Georges Snounou; Jean-Claude Rousselle; Pharat Lim; Jean Koko; Abdelkader Namane; Pierre-André Cazenave; Maryvonne Kombila; Sylviane Pied
Journal:  PLoS One       Date:  2007-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.